Lenvatinib Plus TACE Versus Sorafenib Plus TACE for HCC With PVTT

NCT04127396 · clinicaltrials.gov ↗

PHASE4

Phase

UNKNOWN

Status

72

Enrollment

OTHER

Sponsor class

Conditions

Carcinoma, Hepatocellular
Portal Vein Tumor Thrombus

Interventions

DRUG: Lenvatinib Pill
PROCEDURE: Transarterial chemoembolization(TACE)
DRUG: Sorafenib
PROCEDURE: Transarterial chemoembolization(TACE)

Sponsor

Beijing Ditan Hospital